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Abstract
Background: The increasing population of very old intensive care patients (VIPs) is a major challenge currently faced 
by clinicians and policymakers. Reliable indicators of VIPs’ prognosis and appropriateness of their admission to the 
intensive care unit (ICU) are urgently needed.
Methods: This is a report from the Polish sample of the VIP1 multicentre cohort study (NCT03134807). Patients  
≥ 80 years of age admitted to the ICU were included in the study. Information on the type and reason for admission, 
demographics, utilisation of ICU procedures, ICU length of stay, organ dysfunction and the decision to apply end-of-
-life care was collected. The primary objective was to investigate the impact of frailty syndrome on ICU and 30-day 
survival of VIPs. Frailty was assessed with the Clinical Frailty Scale (≥ 5 points on a scale of 1–9).
Results: We enrolled 272 participants with a median age of 84 (81–87) years. Frailty was diagnosed in 170 (62.5%) 
patients. The ICU and 30-day survival rates were equal to 54.6% and 47.3% respectively. Three variables were found to 
significantly increase the odds of death in the ICU in a multiple logistic regression model, namely: SOFA score (OR = 1.16; 
95% CI: 1.16–1.24); acute mode of admission (OR = 5.1; 95% CI: 1.67–15.57); and frailty (OR = 2.25; 95% CI: 1.26–4.01).
Conclusion: Measuring frailty in critically ill older adults can facilitate making more informed clinical decisions and 
help avoid futile interventions.
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It is estimated that by the year 2050 people at the age 
of 80 years and older will represent almost 10% of the Eu-
ropean population [1]. Progressive ageing remains one of 
the leading issues in contemporary critical care [2]. The 
increasing proportion of elderly patients admitted to ICUs 
requires substantial resources, while many countries are fac-
ing a shortage of ICU beds [3–5]. Although our knowledge 
concerning outcomes in this population is growing, there 
are currently no local reports from Poland [6, 7].
The long-term prognosis of “very old intensive care pa-
tients” (VIPs) is often poor, which requires careful weighing of 
potential costs and benefits associated with intensive care [8]. 
There is a growing recognition of the fact that clinical fea-
tures used in traditional disease severity scores, such as 
APACHE and SAPS, may be insufficient to accurately pre-
dict the outcome in VIPs [2]. Population-specific conditions, 
such as sarcopenia, dementia, delirium and frailty, could be 
incorporated into the evaluation of elderly patients in the 
setting of critical illness in order to help better define their 
prospects of recovery [9–12].
Of the above-mentioned factors, frailty syndrome seems 
to be the most reliable indicator of biological age [13]. Frailty 
is defined as a clinically recognisable state of increased 
vulnerability resulting from ageing-associated decline in 
reserve and function across multiple physiologic systems 
such that the ability to cope with everyday or acute stress-
ors is compromised [14]. Its impact on patients’ outcomes 
is established in geriatric and surgical settings, with less 
evidence available in the field of intensive care. A systematic 
review and meta-analysis by Muscedere et al. [15] showed 
a significant impact of frailty on hospital and long-term mor-
tality in critically ill patients. However, the relevance of these 
results is limited by a moderate quality of included studies.
The Very Old Intensive Care Patient: A Multinational 
Prospective Observation Study (VIP1) was designed to re-
liably address this issue. Its main goal was to assess the 
prevalence of frailty among VIPs and assess its impact on 
their outcomes in the ICU. In the current paper, we would like 
to present results of the VIP1 study based on Polish popula-
tion with a particular interest in frailty and life-sustaining 
treatment limitations, further referred to as end-of-life care 
interchangeably.
Methods
The study was approved by the local ethics commit-
tee (Jagiellonian University Ethics Committee), while the 
protocol complied with the Declaration of Helsinki. Ac-
cording to ethics committee`s verdict, patient consent was 
not required.
VIP1 was a prospective multicentre study coordinated by 
the Health Services Resource and Outcome (HSRO) section 
of the European Society of Intensive Care Medicine (ESICM). 
The enrolment and data collection processes were described 
in detail in the original VIP1 Study [16]. In this paper, we 
reported data from the Polish VIP1 cohort. 
Patients of 80 years of age or older admitted to Polish 
ICUs were considered eligible for the study. We collected 
information on the mode and reason for admission, demo-
graphics, utilisation of ICU procedures (i.e. type of respira-
tory support, administration of vasoactive drugs, initiation 
of renal replacement therapy), ICU length of stay, organ 
dysfunction assessed with SOFA score and the decision to 
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Figure 1. Clinical Frailty Scale
introduce end-of-life care (withholding and/or withdrawal of 
further treatment). Specific definitions had been previously 
described elsewhere [16].
The main objective of the study was to investigate 
the ICU and 30-day survival in relation to the presence 
of frailty syndrome before the onset of acute illness and 
to characterise the intensity of treatment in this group. 
Frailty was assessed with the Clinical Frailty Scale (CFS), 
a simple tool used by the ICU staff according to a visual 
description to categorise patients as frail or non-frail 
(≥ 5 points or < 5 points respectively on a scale of 1–9) 
(Fig. 1) [17]. 
Continuous variables were described as medians with 
interquartile ranges, categorical variables were reported 
as percentage values. The Mann-Whitney U test and chi-
squared test (Pearson’s chi-squared or Fisher’s exact test) 
were used in the between-groups univariate analyses as 
applicable. The effect size was represented by odds ratios 
with 95% confidence intervals. A multiple logistic regression 
model was used to report adjusted odds ratios for the ICU 
mortality of different clinical characteristics. P-values < 0.05 
were considered statistically significant.
Results
Between November 2016 and February 2017, 272 partici-
pants were enrolled in the study. The overall ICU and 30-day 
survival rates were equal to 54.6% and 47.3% respectively. 
Data on ICU survival was available in 269 (98.9%) patients, 
while 239 (87.9%) individuals completed the 30-day follow-up. 
Frailty was diagnosed in 170 (62.5%) patients admitted to ICUs.
The median age of the studied population was 84 (81–
87) years and 159 (58.5%) patients were female. The median 
SOFA score on admission was equal to 10 (7–14). The CFS 
score used to assess frailty reached a median value of 5 
(4–6.75), while the median length of stay in the ICU was 4 
days (1.3–15.9).
Most admissions were classified as acute, with only 42 
(15.4%) patients transferred to the ICU after elective surgery. 
There were 48 (17.6%) patients who stayed less than 24h in 
the ICU (one-day stay). The median time spent in hospital 
before admission to the ICU was 2 days (0–5). The most 
common baseline diagnosis was a combination of circula-
tory and respiratory failure, reported in 72 (26.5%) cases. 
The majority of patients required intubation, mechanical 
ventilation and administration of vasoactive drugs (Table 1).
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Table 1. Differences in clinical characteristics between frail and non-frail patients
Characteristic Not frail
n = 102
Frail
n = 170
P-value
Age (years) 83 (81–85.25) 85 (82–88) 0.004
SOFA score 10 (6–14) 10 (7–14) 0.99
Gender (female) 57.8% 58.8% 0.87
Non-invasive ventilation 7.8% 15.9% 0.06
Intubation & mechanical ventilation 85.3% 84.7% 0.90
Vasoactive drugs 65.7% 74.7% 0.11
Renal replacement therapy 21.6% 19.4% 0.67
Respiratory failure 19.6% 18.2% 0.78
Combined circulatory & respiratory failure 23.5% 28.2% 0.39
Post-elective surgery 20.6% 12.4% 0.07
One-day stay (< 24h at ICU) 19.6% 16.5% 0.51
End-of-life care* 9.8% 16.5% 0.13
Withholding of treatment 6.9% 8.8% 0.57
Withdrawal of treatment 2.9% 7.6% 0.18
ICU length of stay (days) 5.7 (1.1–17.3) 3.1 (1.3–13.1) 0.26
ICU survival 66.3% 47.6% 0.003
30-day survival§ 59.1% 40.4% 0.005
SOFA: Sequential Organ Failure Assessment; ICU: Intensive Care Unit; *End-of-life care: the overall proportion of patients with only withholding and patients with and 
appropriateness (including patients with previous of treatment; §Survival estimates reported after exclusion of patients lost to follow-up (11.2% and 13.7% missing 30-day 
observations of frail and non-frail patients respectively)
In univariate analyses, patients with frailty syndrome 
were older and had a significantly lower ICU and 30-day sur-
vival rate than those without frailty (Table 1). The unadjusted 
OR for death in the ICU associated with frailty was equal to 
2.17 (95% CI: 1.3–3.62; P = 0.003), with a similar effect on 
30-day mortality and an OR of 2.13 (95% CI: 1.26–3.64, P = 
0.005). There were no differences in terms of the baseline 
SOFA score and utilisation of ICU procedures based on the 
presence of frailty. End-of-life care was applied in 16.5% and 
9.8% of the frail and non-frail patients respectively (P = 0.13).
Three variables that significantly increased the odds of 
ICU death were identified in the multiple logistic regression 
model, namely: SOFA score (OR = 1.16; 95% CI: 1.16–1.24); 
acute mode of admission (OR = 5.1; 95% CI: 1.67–15.57); and 
frailty (OR = 2.25; 95% CI: 1.26–4.01) (Table 2). Age was not 
a significant predictor of poor outcome after adjustment for 
other clinical characteristics. An analogous model for 30-day 
mortality exhibited similar findings (results not shown).
An exploratory model investigating whether patients 
lost to follow-up were more severely ill was provided to 
verify the possibility of attrition bias. We found that a com-
bination of SOFA score, frailty and type of admission could 
not predict which patients would leave the study (none of 
these features achieved statistical significance; AUC = 0.56).
Table 2. Multiple logistic regression model — mortality in the ICU
Characteristic Estimate SE P-value Adjusted OR (95%CI)
SOFA score 0.15 0.03 < 0.001 1.16 (1.09–1.24)
Frailty 0.81 0.30 0.006 2.25 (1.26–4.01)
Acute admission 1.63 0.57 0.004 5.10 (1.67–15.57)
Age (years) 0.042 0.037 0.25 1.04 (0.97–1.12)
Gender (female) 0.15 0.28 0.58 1.17 (0.67–2.02)
Intercept –8.96 3.19 0.005 -
SOFA: Sequential Organ Failure Assessment
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discussion
We reported data of 272 very old critically ill patients ad-
mitted to 27 ICUs that took part in the VIP1 Study in Poland [16]. 
The main objective of this multicentre, international study 
was to investigate prospectively the impact of frailty on 
short-term mortality and to describe the level of care in 
this population.
Frailty, assessed with a simple screening tool, was as-
sociated with an over two-fold increase in the odds of death 
independantly of the patient’s age and baseline severity 
of organ failure. The utilisation of medical procedures was 
similar in patients with and without frailty, and there was 
no statistically significant difference between both groups 
in terms of life-sustaining treatment limitations.
The study had a limited sample size due to reporting par-
tial data from a larger cohort study. This did not guarantee 
sufficient power to detect statistically significant differences 
in some characteristics and reduced the cohort’s representa-
tiveness of the population — Polish VIPs had more severe or-
gan dysfunction based on the SOFA score as well as a lower 
ICU and 30-day survival rate than the average reported in 
the VIP1 Study. These observations confirm previous reports 
showing that patients admitted to Polish ICUs are in poor 
clinical condition [18]. However, the observed mortality has 
recently been demonstrated to be lower than predicted by 
the APACHE II model, which might indicate a relatively good 
performance of ICUs in Poland [19].
In the ageing population, the number of critically ill 
elderly patients is increasing [20]. Patients ≥ 80 years old 
account for 10% to 20% of all admissions to the ICU, pos-
ing a global challenge to healthcare systems [21]. Limited 
resources necessitate careful consideration of the potential 
reversibility of critical illness to avoid futile interventions 
[11, 22, 23]. In a recent study in JAMA, Guidet et al. [7] have 
shown that a proactive strategy of admitting elderly patients 
to the ICU (i.e. an ICU triage) doubled the number of admis-
sions to French ICUs and, at the same time, increased hospi-
tal mortality. These findings give rise to a question whether 
we could better predict which VIPs will, in fact, benefit from 
intensive care. Traditional disease severity scores do not 
capture important data on a patient’s premorbid condi-
tion, such as cognitive impairment, decreased functional 
capacity and frailty — all described as potential modifiers 
of morbidity and mortality in VIPs [2]. 
The concept of assessing patients’ biological rather than 
chronological age is appealing and paves its way from geri-
atrics to intensive care. Our results support including frailty 
in the assessment of critically ill elderly patients to improve 
the discrimination between individuals fit for additional 
interventions and those in whom withholding or withdrawal 
of treatment should be considered. This, in turn, should help 
physicians, along with patients and their families, make 
more informed decisions concerning the intensity of treat-
ment, its appropriateness and further course. A study which 
was recently published by Guidet [24] placed frailty among 
the most influential factors with regard to life-sustaining 
treatment limitations, along with acute admission, age and 
SOFA score. The results of the upcoming VIP2 study will 
help establish a predictive model designed specifically for 
the critically ill elderly population, which will take into ac-
count the above-mentioned features [25]. Despite being 
calculated with a dedicated tool, risk estimates alone are 
unlikely to guide treatment in the ICU. However, accurate 
outcome prediction could facilitate clinical judgement and 
improve the communication between providers and reci-
pients of care.
A decision to de-escalate treatment in a particular case 
is never an easy one. In the Polish cohort of VIPs, a deci-
sion to introduce end-of-life care was made in 14% of the 
patients, compared to 27.2% reported across all centres 
participating in the study. These numbers go along with 
results of the paper published by Guidet [24], which showed 
a lower frequency of life-sustaining treatment limitation in 
Eastern Europe. While it does not allow for making direct 
inferences, we should be wary about the fact that many 
patients approaching the end of life tend to value comfort 
over aggressive treatment when given the opportunity to 
express their preferences [26]. The evidence suggests that 
this an often underappreciated practice in the ICU, where 
the patient’s opinion is rarely sought, and the preferences 
of the family are discordant with the care provided in many 
cases [27–29]. Despite the potential short-term benefit of 
treatment in the ICU, the long-term outcome in this popula-
tion is unfavourable [30–32].
Maintenance of life-support measures in patients who 
have no real prospects of recovery is a broadly discussed 
topic. Polish guidelines on intensive care referring to this 
issue considered futile medical therapy as malpractice and 
have highlighted the role of palliative care in this setting [33]. 
This is an important step towards overcoming the legal, 
ethical and religious reservations which may all affect the 
decision whether to de-escalate or discontinue further treat-
ment [24, 34]. The above-mentioned factors are likely to be 
more pronounced in Polish intensivists compared to nation-
alities with a less conservative attitude [35]. In many cases, 
the death of a critically ill elderly patient is a natural history 
of disease rather than a therapeutic failure. Amid the flurry 
of intensive care, we can all benefit from acknowledging 
end-of-life care [36, 37]. 
Nevertheless, we do not all age the same. An octogenar-
ian may still have his greatest mountains to climb ahead 
— just like the famous Mr. Miura, who at the age of eighty, 
against all odds, reached the summit Mount Everest for the 
third time in his life [38]. Thus, adopting the assessment of 
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frailty in critical care has a potential to identify patients who 
are more likely to recover from an acute illness and to act 
upon it with an adequate intensity of intensive care.
conclusions
The presence of frailty increases mortality among criti-
cally ill patients ≥ 80 years old treated in Polish ICUs. Measur-
ing frailty in this population can facilitate making more in-
formed clinical decisions and help avoid futile interventions.
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